ArticleFrontiers in immunology2022

Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report.

Jie Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.